Syndax Pharmaceuticals, Inc

SNDXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

89.2M

on 2026-06-30, from 85.0M on 2024-03-31 10-Q ↗

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

2 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-04 is not read yet.

Cash

9.9 quarters

$547.9M on 2026-06-30 ÷ $55.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 3 of its filings are not read yet.

Also on file: $1K convertible notes, 2026-06-03 8-K ↗ · $1K convertible notes, 2026-06-10 8-K ↗